Cardan Capital Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-49,312
| Closed | -$3.12M | – | 232 |
|
|
2020
Q3 | $3.12M | Buy |
49,312
+2,435
| +5% | +$154K | 0.41% | 81 |
|
|
2020
Q2 | $3.61M | Buy |
46,877
+239
| +0.5% | +$18.4K | 0.52% | 63 |
|
|
2020
Q1 | $3.49M | Sell |
46,638
-1,128
| -2% | -$84.3K | 0.58% | 47 |
|
|
2019
Q4 | $3.1M | Buy |
47,766
+533
| +1% | +$34.6K | 0.42% | 64 |
|
|
2019
Q3 | $2.99M | Buy |
47,233
+2,240
| +5% | +$142K | 0.43% | 64 |
|
|
2019
Q2 | $3.04M | Buy |
44,993
+1,646
| +4% | +$111K | 0.46% | 63 |
|
|
2019
Q1 | $2.82M | Sell |
43,347
-30
| -0.1% | -$1.95K | 0.46% | 61 |
|
|
2018
Q4 | $2.71M | Buy |
43,377
+451
| +1% | +$28.2K | 0.48% | 61 |
|
|
2018
Q3 | $3.31M | Sell |
42,926
-279
| -0.6% | -$21.5K | 0.52% | 56 |
|
|
2018
Q2 | $3.06M | Sell |
43,205
-45
| -0.1% | -$3.19K | 0.5% | 56 |
|
|
2018
Q1 | $3.26M | Buy |
43,250
+226
| +0.5% | +$17K | 0.54% | 51 |
|
|
2017
Q4 | $3.08M | Sell |
43,024
-129
| -0.3% | -$9.24K | 0.58% | 52 |
|
|
2017
Q3 | $3.5M | Buy |
43,153
+78
| +0.2% | +$6.32K | 0.7% | 47 |
|
|
2017
Q2 | $3.05M | Sell |
43,075
-717
| -2% | -$50.8K | 0.59% | 52 |
|
|
2017
Q1 | $2.97M | Sell |
43,792
-511
| -1% | -$34.7K | 0.62% | 51 |
|
|
2016
Q4 | $3.17M | Sell |
44,303
-197
| -0.4% | -$14.1K | 0.71% | 47 |
|
|
2016
Q3 | $3.52M | Sell |
44,500
-622
| -1% | -$49.2K | 0.79% | 43 |
|
|
2016
Q2 | $3.76M | Sell |
45,122
-521
| -1% | -$43.5K | 0.93% | 37 |
|
|
2016
Q1 | $4.19M | Buy |
45,643
+14,745
| +48% | +$1.35M | 1.05% | 36 |
|
|
2015
Q4 | $3.13M | Buy |
+30,898
| New | +$3.13M | 1.34% | 23 |
|